3.17% -0.035

Scynexis Inc (SCYX)

概要ニュース株価時系列オプションチェーン Financials なぜSCYXが下落しているのか？ディスカッション予測株式分割

Relative Volume:

ネットキャッシュフロー:

Scynexis Inc Stock (SCYX) Company Profile

Scynexis Inc

Healthcare (1169)

201-884-5485

1 EVERTRUST PLAZA, JERSEY CITY, NJ

SCYX's Discussions on Twitter

SCYX を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
SCYX Scynexis Inc	1.07	40.60M	135.87M	72.20M	45.09M	1.42
ZTS Zoetis Inc	160.46	71.85B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.08	45.58B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.06	44.58B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.74	19.18B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.60	13.67B	612.78M	-86.37M	-62.91M	-0.87

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2021-01-22	開始されました	Guggenheim	Buy
2021-01-06	開始されました	Cantor Fitzgerald	Overweight
2018-07-11	アップグレード	Needham	Hold → Buy
2018-06-27	開始されました	Maxim Group	Buy
2017-10-24	開始されました	Guggenheim	Buy
2017-07-10	開始されました	ROTH Capital	Buy
2017-05-09	ダウングレード	Needham	Buy → Hold
2017-03-03	繰り返されました	RBC Capital Mkts	Outperform
2016-10-20	開始されました	H.C. Wainwright	Buy
2016-10-07	アップグレード	WBB Securities	Buy → Strong Buy
2016-10-03	再開されました	Brean Capital	Buy
2016-08-17	開始されました	Guggenheim	Buy
2016-08-09	繰り返されました	Needham	Buy
2016-08-09	アップグレード	WBB Securities	Speculative Buy → Buy
2016-03-28	開始されました	Brean Capital	Buy
2015-12-29	開始されました	WBB Securities	Speculative Buy
2015-11-16	繰り返されました	RBC Capital Mkts	Outperform
2015-06-10	開始されました	Needham	Buy
2014-05-29	開始されました	Canaccord Genuity	Buy
2014-05-29	開始されました	RBC Capital Mkts	Outperform

Scynexis Inc (SCYX) 最新ニュース

Scynexis Inc (SCYX) 財務データ

Scynexis Inc (SCYX)

Scynexis Inc Stock (SCYX) Company Profile

SCYX を他の銘柄と比較する

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Scynexis Inc (SCYX) 最新ニュース

SCYNEXIS (NASDAQ:SCYX) Stock Crosses Below 200-Day Moving Average – Time to Sell? - Defense World

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of SCYNEXIS, Inc. (SCYX) Investigation - ACCESS Newswire

SCYNEXIS (NASDAQ:SCYX) Share Price Passes Below 200-Day Moving Average – Should You Sell? - Defense World

Geode Capital Management LLC Acquires 36,405 Shares of SCYNEXIS, Inc. (NASDAQ:SCYX) - Defense World

FEDERATED HERMES, INC. Reduces Stake in SCYNEXIS Inc: A Detailed Analysis - GuruFocus.com

Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail

SCYNEXIS, Inc. (NASDAQ:SCYX) Short Interest Update - Defense World

Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight - GlobeNewswire Inc.

SCYX stock touches 52-week low at $0.97 amid market challenges - Investing.com

SCYNEXIS, Inc. Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections - Marketscreener.com

SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections - The Manila Times

SCYNEXIS Launches Pivotal Phase 1 Trial for Novel Antifungal Drug Against Deadly Infections - StockTitan

SCYX stock touches 52-week low at $1.15 amid market challenges - Investing.com Canada

Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) & SCYNEXIS (NASDAQ:SCYX) - Defense World

SCYNEXIS (NASDAQ:SCYX) adds US$6.5m to market cap in the past 7 days, though investors from five years ago are still down 86% - Simply Wall St

Avidity Partners Management LP's Strategic Acquisition in SCYNEX - GuruFocus.com

Federated Hermes, Inc. Increases Stake in SCYNEXIS Inc - GuruFocus.com

SCYX stock touches 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa

SCYX stock touches 52-week low at $1.25 amid market challenges - Investing.com

SCYNEXIS announces new $50 million equity sales agreement By Investing.com - Investing.com Australia

SCYNEXIS Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

Scynexis Inc earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada

Scynexis: Q3 Earnings Snapshot - San Francisco Chronicle

SCYNEXIS announces new $50 million equity sales agreement - Investing.com India

SCYNEXIS Secures $10M GSK Milestone, Advances Antifungal Pipeline Despite Q3 Revenue Dip | SCYX Stock News - StockTitan

SCYNEXIS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. In - GuruFocus.com

Investors in SCYNEXIS (NASDAQ:SCYX) have unfortunately lost 89% over the last five years - Yahoo Finance

SCYNEXIS (NASDAQ:SCYX) Shares Pass Above Fifty Day Moving AverageShould You Sell? - MarketBeat

SCYNEXIS (NASDAQ:SCYX) Stock Price Passes Below Two Hundred Day Moving AverageHere's Why - MarketBeat

SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times

Federated Hermes, Inc. Expands Stake in SCYNEXIS Inc - Yahoo Finance

SCYNEXIS (NASDAQ:SCYX) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat

SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024 - The Manila Times

SCYNEXIS (NASDAQ:SCYX) Shares Pass Below 200 Day Moving Average of $1.82 - MarketBeat

CRISPR Therapeutics: Prepare To Be Bored (NASDAQ:CRSP) - Seeking Alpha

Potential Price Increase for Synopsys, Inc. (SNPS) After Recent Insider Activity - Knox Daily

Scynexis CEO acquires $27,400 in company stock By Investing.com - Investing.com Canada

Syncona Advances Share Buyback, Bolsters Treasury Shares - TipRanks

Xero buys South African firm for $115m in 'departure' - New Zealand Herald

SCYNEXIS, Inc. (NASDAQ:SCYX) CEO Gonzalez David Angulo Buys 20,000 Shares - MarketBeat

Scynexis Inc (SCYX) 財務データ

収益

当期純利益

現金流量

EPS

SCYXに似た銘柄